| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $433.0M | +10.6% |
| Cost of Revenue | $103.6M | +1.0% |
| Gross Profit | $329.4M | +13.9% |
| R&D Expense | $127.7M | +20.9% |
| SG&A Expense | $107.0M | +25.7% |
| Operating Income | -$82.9M | -35.9% |
| Pre-tax Income | -$77.7M | -49.5% |
| Income Tax | $1.9M | +132.6% |
| Net Income | -$79.6M | -50.8% |
| EPS (Basic) | -$0.49 | -48.5% |
| EPS (Diluted) | -$0.49 | -48.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $274.5M | -14.7% |
| Accounts Receivable | $31.4M | +6.7% |
| Current Assets | $324.3M | -12.4% |
| Total Assets | $605.4M | -6.8% |
| Current Liabilities | $233.0M | -9.7% |
| Stockholders' Equity | $353.9M | -4.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.1M | -332.4% |
| Capital Expenditures | $802K | +80.2% |
| Investing Cash Flow | $830K | +112.2% |
| Financing Cash Flow | -$10.6M | -105.2% |
| Free Cash Flow | -$37.9M | -344.2% |